[F-18 FDG PET in dementia]
- PMID: 2601095
[F-18 FDG PET in dementia]
Abstract
Glucose metabolism was measured by F-18 FDG PET in 33 patients with dementia. In patients with DAT, rCMRgl showed marked decrease in the associated areas in the temporo-parietal lobes, and it was relatively preserved in the primary cortices such as sensory, motor and visual areas. Frontal lobes were also involved in patients with advanced disease. In Pick disease, the frontal lobes were severely impaired. Multi-infarct dementia, Parkinson dementia and supranuclear palsy showed diffuse or multiple involvement throughout the entire brain. Correlation with rCMRgl and clinical severity was found in DAT patients. In conclusion, F-18 FDG PET is clinically useful in the differential diagnosis and grading of dementias.
Similar articles
-
[Cerebral glucose metabolism in dementia (PET-FDG study)].Rinsho Hoshasen. 1989 Oct;34(11):1343-8. Rinsho Hoshasen. 1989. PMID: 2601096 Japanese.
-
Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study.J Nucl Med. 1989 May;30(5):581-90. J Nucl Med. 1989. PMID: 2785582
-
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.Arch Neurol. 1983 Nov;40(12):711-4. doi: 10.1001/archneur.1983.04050110029003. Arch Neurol. 1983. PMID: 6605139
-
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].Nihon Rinsho. 1997 Jan;55(1):222-6. Nihon Rinsho. 1997. PMID: 9014454 Review. Japanese.
-
Functional brain imaging in late-life depression and dementia.J Clin Psychiatry. 1993 Nov;54 Suppl:21-5. J Clin Psychiatry. 1993. PMID: 8270594 Review.
MeSH terms
Substances
LinkOut - more resources
Medical